These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33007853)

  • 1.
    Herrera-Hidalgo L; de Alarcón A; López-Cortes LE; Luque-Márquez R; López-Cortes LF; Gutiérrez-Valencia A; Gil-Navarro MV
    Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 33007853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of
    Herrera-Hidalgo L; Fernández-Rubio B; Luque-Márquez R; López-Cortés LE; Gil-Navarro MV; de Alarcón A
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV; Lopez-Cortes LE; Luque-Marquez R; Galvez-Acebal J; de Alarcon-Gonzalez A
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dalbavancin for Successful Treatment of Infective Endocarditis Caused by
    Teigell-Muñoz FJ; Mateos-González M; Bernal Hertfelder E; Sánchez de Torre A; García-Ferrón M; de Cáceres Velasco C; Bueno Muiño C
    Eur J Case Rep Intern Med; 2023; 10(1):003654. PubMed ID: 36819647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin Plus Ceftriaxone Combined Therapy for
    Herrera-Hidalgo L; Lomas-Cabezas JM; López-Cortés LE; Luque-Márquez R; López-Cortés LF; Martínez-Marcos FJ; de la Torre-Lima J; Plata-Ciézar A; Hidalgo-Tenorio C; García-López MV; Vinuesa D; Gutiérrez-Valencia A; Gil-Navarro MV; De Alarcón A
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin for treating enterococcal infective endocarditis: A retrospective observational study from a referral centre in Spain.
    Escolà-Vergé L; Fernández-Hidalgo N; Rodríguez-Pardo D; Pigrau C; González-López JJ; Bartolomé R; Almirante B
    Int J Antimicrob Agents; 2019 Feb; 53(2):165-170. PubMed ID: 30315920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of teicoplanin monotherapy following initial standard therapy in Enterococcus faecalis infective endocarditis: a retrospective cohort study.
    De Nadaï T; François M; Sommet A; Dubois D; Metsu D; Grare M; Marchou B; Delobel P; Martin-Blondel G
    Infection; 2019 Jun; 47(3):463-469. PubMed ID: 30809761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.
    Leone S; Noviello S; Esposito S
    Infection; 2016 Jun; 44(3):273-81. PubMed ID: 26324294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampicillin Plus Ceftriaxone Regimen against
    Marino A; Munafò A; Zagami A; Ceccarelli M; Di Mauro R; Cantarella G; Bernardini R; Nunnari G; Cacopardo B
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640612
    [No Abstract]   [Full Text] [Related]  

  • 10. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.
    El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM
    J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review.
    Marino A; Munafò A; Zagami A; Ceccarelli M; Campanella E; Cosentino F; Moscatt V; Cantarella G; Di Mauro R; Bernardini R; Nunnari G; Cacopardo B
    IDCases; 2022; 28():e01462. PubMed ID: 35265458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of different antibiotic regimens for the treatment of infective endocarditis.
    Martí-Carvajal AJ; Dayer M; Conterno LO; Gonzalez Garay AG; Martí-Amarista CE; Simancas-Racines D
    Cochrane Database Syst Rev; 2016 Apr; 4():CD009880. PubMed ID: 27092951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterococcal endocarditis revisited.
    Pericás JM; Zboromyrska Y; Cervera C; Castañeda X; Almela M; Garcia-de-la-Maria C; Mestres C; Falces C; Quintana E; Ninot S; Llopis J; Marco F; Moreno A; Miró JM
    Future Microbiol; 2015; 10(7):1215-40. PubMed ID: 26118390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycosides for infective endocarditis: time to say goodbye?
    Lebeaux D; Fernández-Hidalgo N; Pilmis B; Tattevin P; Mainardi JL
    Clin Microbiol Infect; 2020 Jun; 26(6):723-728. PubMed ID: 31669426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres.
    Sader HS; Mendes RE; Pfaller MA; Flamm RK
    J Antimicrob Chemother; 2019 May; 74(5):1306-1310. PubMed ID: 30753485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
    Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
    Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.
    Partridge DG; O'Brien E; Chapman AL
    Postgrad Med J; 2012 Jul; 88(1041):377-81. PubMed ID: 22366395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
    Moreillon P; Wilson WR; Leclercq R; Entenza JM
    Antimicrob Agents Chemother; 2007 May; 51(5):1661-5. PubMed ID: 17353251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.